Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityNo recent work listed

Lei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0530-8015; OpenAlex author ID A5067105789. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper

Papers 2

  1. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and β-catenin signaling in pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1053/j.gastro.2014.04.048↗
  2. ABCB2 (TAP1) as the downstream target of SHH signaling enhances pancreatic ductal adenocarcinoma drug resistance. First author DOI 10.1016/j.canlet.2013.01.002↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiangyu Kong · 2 shared papers, 2013–2014 · strength 0.08
  2. Dacheng Xie · 1 shared paper, 2014 · strength 0.04
  3. Daoyan Wei · 1 shared paper, 2014 · strength 0.04
  4. Weihua Jiang · 1 shared paper, 2014 · strength 0.04
  5. Yiqi Du · 1 shared paper, 2014 · strength 0.04
  6. Zhaoshen Li · 1 shared paper, 2014 · strength 0.04
  7. Jiujie Cui · 1 shared paper, 2014 · strength 0.04
  8. Keping Xie · 1 shared paper, 2014 · strength 0.04
  9. Youli Zhang · 1 shared paper, 2013 · strength 0.04
  10. Min Xu · 1 shared paper, 2013 · strength 0.04
  11. Haojie Huang · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.